A retrospective study comparing the severe cutaneous adverse reactions in patients receiving triazole antifungal therapy and literature analysis. [PDF]
Jin CT, Jiang QQ, Chen P, Jiang W.
europepmc +1 more source
Use of Expanded Access Fosmanogepix in Two Pediatric Patients With Rhino-Orbital-Cerebral Mucormycosis. [PDF]
Oldham MM +4 more
europepmc +1 more source
Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment [PDF]
Özkocaman V +7 more
europepmc +1 more source
Mucormycosis in adult hematopoietic stem cell transplant recipients during the antifungal prophylaxis era: a single-center retrospective case series. [PDF]
Shiari A, Pennington K, Yadav H.
europepmc +1 more source
Tonsillar <i>mucormycosis</i> in an immunocompetent young woman: a case report. [PDF]
Haddad M +3 more
europepmc +1 more source
<i>In vitro</i> susceptibility and provisional epidemiological cutoff values for eight antifungal agents against <i>Trichophyton mentagrophytes</i> and <i>Trichophyton interdigitale</i>: a multicenter study from China. [PDF]
Zheng H +18 more
europepmc +1 more source
Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges. [PDF]
Yin Y, Lu W, Zhao M, Zhao Y.
europepmc +1 more source
Successful treatment of severe influenza-associated pulmonary aspergillosis with invasive tracheobronchitis and bronchial asthma using combination antifungals and omalizumab: A case report. [PDF]
Du W, Lv H, Ni Y, Ding Y.
europepmc +1 more source
New Organic Compounds Against <i>Scedosporium</i> and Mucorales: Antifungal Activity and Mechanisms of Cell Wall and Membrane Disruption. [PDF]
Rollin-Pinheiro R +12 more
europepmc +1 more source
Pharmacological treatment, adversities, and mobile-based post-discharge follow-up of mucormycosis survivors in Central India: strengthening patient care. [PDF]
Baghel R, Acharya P, Verma A, Sharma M.
europepmc +1 more source

